Whether you need a Chief Financial Officer to lead a Series B funding process or a senior accountant to build out the finance function inside a regulated quality environment, the finance profile in MedTech is more nuanced than the job title suggests.
The capital environment these leaders are operating in has rarely been more active or complex. According to EY's 2025 Pulse of the MedTech Industry report, venture capital investment in MedTech surged 16% in 2025, with average financing rounds reaching $36 million - a 122% increase over 2024, reflecting a market concentrating capital in fewer, higher-conviction bets. M&A average deal sizes hit $497 million, up 72% on the prior decade's average. The finance leaders responsible for deploying, reporting on, and protecting that capital are making decisions that determine whether a company can sustain its clinical and commercial roadmap to the next milestone.
The profile that succeeds in this environment combines technical financial competence with a deep understanding of how MedTech businesses operate. The right hire understands the regulatory triggers that can reshape a budget overnight, the clinical milestones that unlock the next funding round, and the reimbursement decisions that determine whether a commercial plan is viable.